Advances in sensing electronics and signal processing are paving the way for glucose monitors that have the potential to eliminate the need for invasive blood sampling. Noninvasive monitors winding their way through the development and clinical trial process include novel optical, RF, and thermal designs. “The ability to monitor glucose levels in a painless and consistent way has the potential to improve the quality of life for millions of diabetes patients,” explains George Perros, Greystone Managing Director. “It’s a daunting technical challenge that must take into account the user needs of patients across a broad socioeconomic spectrum. These monitors must be extremely accurate and reliable, and usable by almost anyone. Successful companies will be those that have the ability to attract and manage financial resources over a protracted product development cycle.”
These findings are contained in a new and comprehensive report: Noninvasive Glucose Monitors: Technology, Players and Prospects. The report includes a comprehensive assessment of current and planned noninvasive glucose monitoring products, profiles of market participants, noninvasive technology evaluations and risk factors, revenue forecasts, and detailed analysis of regulatory and market factors.
More information is available at www.greystoneassociates.org .
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
www.greystoneassociates.org Source: Greystone Associates
For more information:
Last updated on: 27/08/2010
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.